Gene · 7220
Papers2,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis. | Front Genet | 2022 | 35711942 | PubTator, text mining | PubMed |
| Child type 1 diabetes associated with mother vaginal bacteriome and mycobiome. | Med Microbiol Immunol | 2022 | 35701558 | PubTator, text mining | PubMed |
| The role of circular RNA in Diabetic Nephropathy. | Int J Med Sci | 2022 | 35693742 | PubTator, text mining | PubMed |
| Activity dependent inhibition of TRPC1/4/5 channels by duloxetine involves voltage sensor-like domain. | Biomed Pharmacother | 2022 | 35691156 | PubTator, text mining | PubMed |
| Sequence and structural conservation reveal fingerprint residues in TRP channels. | Elife | 2022 | 35686986 | PubTator, text mining | PubMed |
| ORAI1-Regulated Gene Expression in Breast Cancer Cells: Roles for STIM1 Binding, Calcium Influx and Transcription Factor Translocation. | Int J Mol Sci | 2022 | 35682546 | PubTator, text mining | PubMed |
| Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway. | Postepy Dermatol Alergol | 2022 | 35645678 | PubTator, text mining | PubMed |
| The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. | Biomedicines | 2022 | 35625694 | PubTator, text mining | PubMed |
| The Mechanism and Regulation of the NLRP3 Inflammasome during Fibrosis. | Biomolecules | 2022 | 35625564 | PubTator, text mining | PubMed |
| TRP Family Genes Are Differently Expressed and Correlated with Immune Response in Glioma. | Brain Sci | 2022 | 35625048 | PubTator, text mining | PubMed |
| Identification of TRP-Related Subtypes, Development of a Prognostic Model, and Characterization of Tumor Microenvironment Infiltration in Lung Adenocarcinoma. | Front Mol Biosci | 2022 | 35620481 | PubTator, text mining | PubMed |
| Pan-cancer analyses reveal the genetic and pharmacogenomic landscape of transient receptor potential channels. | NPJ Genom Med | 2022 | 35614079 | PubTator, text mining | PubMed |
| TRPC1 contributes to endotoxemia-induced myocardial dysfunction via mediating myocardial apoptosis and autophagy. | Pharmacol Res | 2022 | 35598715 | PubTator, text mining | PubMed |
| TRP Channels as Molecular Targets to Relieve Endocrine-Related Diseases. | Front Mol Biosci | 2022 | 35573736 | PubTator, text mining | PubMed |
| Treatment of Gastrointestinal Disorders-Plants and Potential Mechanisms of Action of Their Constituents. | Molecules | 2022 | 35566230 | PubTator, text mining | PubMed |
| TRPM8-Rap1A Interaction Sites as Critical Determinants for Adhesion and Migration of Prostate and Other Epithelial Cancer Cells. | Cancers (Basel) | 2022 | 35565390 | PubTator, text mining | PubMed |
| Granzymes-Their Role in Colorectal Cancer. | Int J Mol Sci | 2022 | 35563668 | PubTator, text mining | PubMed |
| Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1-Alkyl-2-(pyrrolidin-1-yl)-1H-benzo[d]imidazoles as Potent and Selective Inhibitors. | ChemMedChem | 2022 | 35557491 | PubTator, text mining | PubMed |
| Cross-talk between TRPC-1, mTOR, PGC-1α and PPARδ in the dystrophic muscle cells treated with tempol. | Free Radic Res | 2022 | 35549793 | PubTator, text mining | PubMed |
| Transient Receptor Potential Channel 1 Potentially Serves as a Biomarker Indicating T/TNM Stages and Predicting Long-Term Prognosis in Patients With Renal Cell Carcinoma. | Front Surg | 2022 | 35548183 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7220/papers?page=23